(Q57269407)

24

0 references

Akira Hata

27

object named as

A Hata

0 references

author name string

Y Onouchi

1

0 references

Y Suzuki

2

0 references

H Suzuki

3

0 references

M Terai

4

0 references

K Yasukawa

5

0 references

H Hamada

6

0 references

T Suenaga

7

0 references

T Honda

8

0 references

A Honda

9

0 references

H Kobayashi

10

0 references

T Takeuchi

11

0 references

N Yoshikawa

12

0 references

J Sato

13

0 references

S Shibuta

14

0 references

M Miyawaki

15

0 references

K Oishi

16

0 references

H Yamaga

17

0 references

N Aoyagi

18

0 references

S Iwahashi

19

0 references

R Miyashita

20

0 references

Y Murata

21

0 references

R Ebata

22

0 references

K Higashi

23

0 references

K Sasago

The Pharmacogenomics Journal

25

0 references

publication date

11 October 2011

0 references

published in

0 references

volume

13

0 references

issue

1

0 references

page(s)

52-59

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/tpj.2011.45

0 references

cites work

Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.45

A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.45

ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.45

Common variants in CASP3 confer susceptibility to Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.45

Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008)--digest version

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.45

Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.45

Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.45

Increased incidence and severity of Kawasaki disease among Filipino-Americans in San Diego county

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.45

Initial intravenous gamma-globulin treatment failure in Iranian children with Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.45

Molecular genetics of Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.45

ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.45

CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.45

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.45

Proteolytic regulation of nuclear factor of activated T (NFAT) c2 cells and NFAT activity by caspase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.45